{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:49:01Z","timestamp":1792511341678,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014112","name":"NSW Department of Planning,Industry and Environment","doi-asserted-by":"publisher","award":["KR_2019_09"],"award-info":[{"award-number":["KR_2019_09"]}],"id":[{"id":"10.13039\/501100014112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021708","name":"New South Wales Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jvacx.2023.100329","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T23:37:53Z","timestamp":1686181073000},"page":"100329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Reduction of Chlamydia pecorum and Koala Retrovirus subtype B expression in wild koalas vaccinated with novel peptide and peptide\/recombinant protein formulations"],"prefix":"10.1016","volume":"14","author":[{"given":"Bonnie L","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Timms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6295-529X","authenticated-orcid":false,"given":"Sharon","family":"Nyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2432-4811","authenticated-orcid":false,"given":"Philippa","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-4600","authenticated-orcid":false,"given":"Jon","family":"Hanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2549-8111","authenticated-orcid":false,"given":"Samuel","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2023.100329_b0005","unstructured":"Government A. Phascolarctos cinereus (combined populations of Qld, NSW and the ACT), in Species Profile and Threats Database, W.a.t.E. Department of Agriculture, Editor. 2022: https:\/\/www.environment.gov.au\/cgi-bin\/sprat\/public\/publicspecies.pl?taxon_id=85104."},{"key":"10.1016\/j.jvacx.2023.100329_b0010","unstructured":"Blanshard Wendy BK. Medicine of Australian mammals, ed. r.w. Adrienne de Kretser. 2008, CSIRO Publishing, 150 Oxford Street, Collingwood, Victoria, Australia, 3066: CSIRO Publishing. 686."},{"issue":"12","key":"10.1016\/j.jvacx.2023.100329_b0015","doi-asserted-by":"crossref","first-page":"e0190114","DOI":"10.1371\/journal.pone.0190114","article-title":"Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population","volume":"12","author":"Nyari","year":"2017","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jvacx.2023.100329_b0020","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.vaccine.2011.12.125","article-title":"Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology","volume":"30","author":"Kollipara","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jvacx.2023.100329_b0025","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.vaccine.2012.12.057","article-title":"Antigenic specificity of a monovalent versus polyvalent MOMP based Chlamydia pecorum vaccine in koalas (Phascolarctos cinereus)","volume":"31","author":"Kollipara","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jvacx.2023.100329_b0030","doi-asserted-by":"crossref","first-page":"e74808","DOI":"10.1371\/journal.pone.0074808","article-title":"Vaccination of koalas with a recombinant Chlamydia pecorum major outer membrane protein induces antibodies of different specificity compared to those following a natural live infection","volume":"8","author":"Kollipara","year":"2013","journal-title":"PLoS ONE"},{"issue":"44","key":"10.1016\/j.jvacx.2023.100329_b0035","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2014.08.037","article-title":"Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses","volume":"32","author":"Khan","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100329_b0040","doi-asserted-by":"crossref","first-page":"e0156094","DOI":"10.1371\/journal.pone.0156094","article-title":"Antibody and cytokine responses of koalas (Phascolarctos cinereus) vaccinated with recombinant chlamydial Major Outer Membrane Protein (MOMP) with two different adjuvants","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100329_b0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.vaccine.2015.12.050","article-title":"Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine","volume":"34","author":"Khan","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0050","doi-asserted-by":"crossref","first-page":"e0146934","DOI":"10.1371\/journal.pone.0146934","article-title":"A prototype recombinant-protein based Chlamydia pecorum vaccine results in reduced chlamydial burden and less clinical disease in free-ranging koalas (Phascolarctos cinereus)","volume":"11","author":"Waugh","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100329_b0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.biologicals.2016.09.006","article-title":"Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)","volume":"44","author":"Waugh","year":"2016","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100329_b0060","doi-asserted-by":"crossref","first-page":"e0178786","DOI":"10.1371\/journal.pone.0178786","article-title":"Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance","volume":"12","author":"Desclozeaux","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0065","doi-asserted-by":"crossref","first-page":"e0210245","DOI":"10.1371\/journal.pone.0210245","article-title":"Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus)","volume":"14","author":"Nyari","year":"2019","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67208-x","article-title":"Vaccination of koalas during antibiotic treatment for Chlamydia-induced cystitis induces an improved antibody response to Chlamydia pecorum","volume":"10","author":"Phillips","year":"2020","journal-title":"Sci Rep"},{"issue":"JAN","key":"10.1016\/j.jvacx.2023.100329_b0075","article-title":"Seventy years of Chlamydia vaccine research - Limitations of the past and directions for the future","volume":"10","author":"Phillips","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0080","doi-asserted-by":"crossref","DOI":"10.2981\/wlb.00627","article-title":"A proposed roadmap for the control of infections in wildlife using Chlamydia vaccine development in koalas Phascolarctos cinereus as a template","volume":"2020","author":"Waugh","year":"2020","journal-title":"Wildl Biol"},{"key":"10.1016\/j.jvacx.2023.100329_b0085","doi-asserted-by":"crossref","unstructured":"Nyari S et al. Vaccination of koalas (Phascolarctos cinereus) against chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. PLoS ONE 2018;13(6).","DOI":"10.1371\/journal.pone.0200112"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100329_b0090","doi-asserted-by":"crossref","first-page":"e01871","DOI":"10.1128\/JVI.01871-17","article-title":"Molecular dynamics and mode of transmission of koala retrovirus as it invades and spreads through a wild Queensland koala population","volume":"92","author":"Quigley","year":"2018","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0095","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1038\/s41598-019-47666-8","article-title":"Altered immune parameters associated with Koala Retrovirus (KoRV) and Chlamydial infection in free ranging Victorian koalas (Phascolarctos cinereus)","volume":"9","author":"Maher","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jvacx.2023.100329_b0100","doi-asserted-by":"crossref","first-page":"e0163780","DOI":"10.1371\/journal.pone.0163780","article-title":"Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas","volume":"11","author":"Maher","year":"2016","journal-title":"PLoS ONE"},{"issue":"28","key":"10.1016\/j.jvacx.2023.100329_b0105","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.1073\/pnas.1304704110","article-title":"An exogenous retrovirus isolated from koalas with malignant neoplasias in a US zoo","volume":"110","author":"Xu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0110","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41467-021-21612-7","article-title":"Retroviral integrations contribute to elevated host cancer rates during germline invasion","volume":"12","author":"McEwen","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41541-018-0066-4","article-title":"Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein","volume":"3","author":"Olagoke","year":"2018","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48880-0","article-title":"Antibody response against koala retrovirus (KoRV) in koalas harboring KoRV-A in the presence or absence of KoRV-B","volume":"9","author":"Olagoke","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0210-9","article-title":"Therapeutic vaccination of koalas harbouring endogenous koala retrovirus (KoRV) improves antibody responses and reduces circulating viral load","volume":"5","author":"Olagoke","year":"2020","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-020-01442-7","article-title":"Koalas vaccinated against Koala retrovirus respond by producing increased levels of interferon-gamma","volume":"17","author":"Olagoke","year":"2020","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0135","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1038\/s41598-019-49382-9","article-title":"Longitudinal study of wild koalas (Phascolarctos cinereus) reveals chlamydial disease progression in two thirds of infected animals","volume":"9","author":"Robbins","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvacx.2023.100329_b0140","unstructured":"Team RC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018."},{"key":"10.1016\/j.jvacx.2023.100329_b0145","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100329_b0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nbt0308-293","article-title":"Digital mRNA profiling","volume":"26","author":"Fortina","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"20","key":"10.1016\/j.jvacx.2023.100329_b0155","first-page":"e151","article-title":"NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.jvacx.2023.100329_b0160","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/mr.58.4.686-699.1994","article-title":"Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis","volume":"58","author":"Beatty","year":"1994","journal-title":"Microbiol Rev"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100329_b0165","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/iai.65.6.1993-1999.1997","article-title":"Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice","volume":"65","author":"Su","year":"1997","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.jvacx.2023.100329_b0170","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1128\/iai.55.10.2387-2390.1987","article-title":"Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice","volume":"55","author":"Williams","year":"1987","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.jvacx.2023.100329_b0175","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1128\/iai.65.7.2876-2882.1997","article-title":"Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis","volume":"65","author":"Williams","year":"1997","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100329_b0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2567.2001.01167.x","article-title":"Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells","volume":"102","author":"Johansson","year":"2001","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100329_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2015.02.004","article-title":"A re-evaluation of the role of B cells in protective immunity to Chlamydia infection","volume":"164","author":"Li","year":"2015","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0190","first-page":"9","article-title":"Immune-mediated control of Chlamydia infection","volume":"10","author":"Roan","year":"2008","journal-title":"Cell Microbiol"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100329_b0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/viru.1.5.12862","article-title":"IL-17 in protective immunity to intracellular pathogens","volume":"1","author":"Khader","year":"2010","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.jvacx.2023.100329_b0200","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.0901584","article-title":"IL-17\/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function","volume":"183","author":"Bai","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100329_b0205","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cyto.2011.06.027","article-title":"Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae","volume":"56","author":"Rizzo","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100329_b0210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10753-013-9719-7","article-title":"Seminal levels of IL-10, IL-12, and IL-17 in men with asymptomatic chlamydia infection","volume":"37","author":"Hakimi","year":"2014","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100329_b0215","doi-asserted-by":"crossref","first-page":"e39214","DOI":"10.1371\/journal.pone.0039214","article-title":"IL-17A synergizes with IFN-\u03b3 to upregulate iNOS and NO production and inhibit chlamydial growth","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jvacx.2023.100329_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639834","article-title":"Insights into host cell cytokines in Chlamydia infection","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Immunol"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:30:22Z","timestamp":1792510222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":44,"alternative-id":["S2590136223000700"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100329","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Chlamydia pecorum and Koala Retrovirus subtype B expression in wild koalas vaccinated with novel peptide and peptide\/recombinant protein formulations","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100329"}}